European Graves’ disease Market 2019: Global Industry Analysis Report to 2025
European Graves’ disease market is growing at a CAGR of around 4.4% during the forecast period. Europe consists of numerous key economies including the UK, Germany, Spain, Italy, and Russia among various others which play a significant role in the development of the Grave’s market in the region. The key reason which is promoting the growth of the market in Europe is the changing lifestyle and higher prevalence of smoking in the countries of European region is expected to promote the prevalence of Grave’s disease, thereby creating opportunity for the growth of the European Graves’ diseases market over the forecast period.
To Request a Sample of our Report on European
Graves’ disease Market: https://www.omrglobal.com/request-sample/european-graves-disease-market
Europe is the well-established
region comprises of few of the largest economies of the world. The region has
established healthcare industry due to growing funding in the healthcare
R&D and awareness programs. This directly impacts the funding and awareness
about thyroid related diseases such as Grave’s disease, thyroid cancer and
others. Presence of the key market players such as Apitope technology Ltd.,
GlaxoSmithKline PLC and others is also affecting the growth of the market.
Growing prevalence of type-1 diabetes is one of the major factors contributing
significantly in the European Grave’s disease market.
Further, Apitope International NV
is a biotechnology company, based in Belgium, that manufactures and markets
commercialized products for autoimmune disease. The company provides product
candidate ATX-GD-59 that is a disease-modifying treatment for Grave’s disease.
ATX-GD-59 is presently being assessed in a Phase I study in patients and the
company plans to initiate a Phase II study in the first quarter of 2019. Thus,
the presence of the market players strengthens the domestic presence and also
aids in the growth of the European Graves’ disease market.
(Get 15% Discount on Buying this Report)
A
full Report of European Graves’ disease Market is Available @ https://www.omrglobal.com/industry-reports/european-graves-disease-market
European Graves’ disease Market Segmentation
By Diagnosis
·
Ultrasound
·
Imaging Tests
·
Radioactive Iodine Uptake
·
Blood Sample
By Treatment
·
Anti- Thyroid Medication
·
Radioactive Iodine Therapy
·
Surgery
Regional Analysis
·
UK
·
Germany
·
France
·
Italy
·
Spain
Rest of Europe
Company Profiles
·
Abbott Laboratories Inc.
·
Allergan PLC
·
Eli Lilly and Co.
·
GlaxoSmithKline PLC
·
Johnson & Johnson
·
Macleods Pharmaceuticals Ltd.
·
Merck & Co. Inc
·
Mylan NV
·
Novartis International AG
·
Pfizer Inc.
·
Sanofi SA
·
Takeda Pharmaceutical Co. Ltd.
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment